Cefepime hydrochloride and Thrombocytopenia - a phase IV clinical study of FDA data
Thrombocytopenia is found among people who take Cefepime hydrochloride, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Cefepime hydrochloride and have Thrombocytopenia. It is created by eHealthMe based on reports of 993 people who have side effects when taking Cefepime hydrochloride from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
993 people reported to have side effects when taking Cefepime hydrochloride.
Among them, 91 people (9.16%) have Thrombocytopenia.
What is Cefepime hydrochloride?
Cefepime hydrochloride has active ingredients of cefepime hydrochloride. eHealthMe is studying from 1,015 Cefepime hydrochloride users for its effectiveness, alternative drugs and more.
What is Thrombocytopenia?
Thrombocytopenia (decrease of platelets in blood) is found to be associated with 3,645 drugs and 4,062 conditions by eHealthMe.
Number of Cefepime hydrochloride and Thrombocytopenia reports submitted per year:
Time on Cefepime hydrochloride when people have Thrombocytopenia *:
Gender of people who have Thrombocytopenia when taking Cefepime hydrochloride*:
Age of people who have Thrombocytopenia when taking Cefepime hydrochloride *:
Common drugs people take besides Cefepime hydrochloride *:
Common side effects people have besides Thrombocytopenia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Cefepime hydrochloride and have Thrombocytopenia?Check whether Thrombocytopenia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
- Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
- Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
Alternative drugs to, pros and cons of Cefepime hydrochloride:
- Cefepime hydrochloride (1,015 reports)
Thrombocytopenia treatments and more:
- Thrombocytopenia (226,175 reports)
COVID vaccines that are related to Thrombocytopenia:
- Thrombocytopenia in Moderna COVID Vaccine
- Thrombocytopenia in Pfizer BioNTech Covid Vaccine
- Thrombocytopenia in Johnson and Johnson Covid Vaccine
How severe was Thrombocytopenia and when was it recovered:
Expand to all the drugs that have ingredients of cefepime hydrochloride:
Common drugs associated with Thrombocytopenia:
All the drugs that are associated with Thrombocytopenia:
- Thrombocytopenia (3,645 drugs)
Common conditions associated with Thrombocytopenia:
All the conditions that are associated with Thrombocytopenia:
- Thrombocytopenia (4,062 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cefepime hydrochloride (the active ingredients of Cefepime hydrochloride) and Cefepime hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.